Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Autism Spectrum Disorder (Phase 1/Phase 2)
Autistic Disorder (Phase 1/Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Burkitt Lymphoma (Phase 2)
Burns (Phase 1/Phase 2)
Cerebral Palsy (Phase 2)
Diabetic Foot (Phase 3)
Fasting (Phase 1)
Heart Defects, Congenital (Phase 1)
Hematologic Neoplasms (Phase 2)
Hypoplastic Left Heart Syndrome (Phase 1)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Poisoning (Phase 2)
Primary Ovarian Insufficiency (Phase 2)
Spinal Cord Injuries (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue